Top 50 thought-leaders in orphan drugs and rare disease

Recognizing representatives from industry, patient advocacy, government and more who are leading the way in the orphan drug community

This report recognizes the top 50 thought-leaders in orphan drugs and rare disease. Thought-leaders include representatives from industry, patient advocacy groups, research institutions, government and media from around the world.

They were  selected based on the following criteria:

  • Research & methodology
  • Leadership
  • Awards & recognition
  • Community engagement & impact

Download a copy of the report today to find out who is pioneering orphan drug research, awareness and legislation.

Some quick details
Email address:*
First name:*
Last name:*
Do you provide solutions & products
for this industry?*
What is your role?*
Would you like to subscribe to our
weekly e-newsletter?

Privacy statement »

Remember my details Information

Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Manage your email preferences »

You will be emailed the document as an attachment (1,337Kb in size)